An inducible circular RNA circKcnt2 inhibits ILC3 activation to facilitate colitis resolution
Group 3 innate lymphoid cells (ILC3) are an important regulator for immunity, inflammation and tissue homeostasis in the intestine, but how ILC3 activation is regulated remains elusive. Here we identify a new circular RNA (circRNA) circKcnt2 that is induced in ILC3s during intestinal inflammation. D...
Saved in:
Published in: | Nature communications Vol. 11; no. 1; p. 4076 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
14-08-2020
Nature Publishing Group Nature Portfolio |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Group 3 innate lymphoid cells (ILC3) are an important regulator for immunity, inflammation and tissue homeostasis in the intestine, but how ILC3 activation is regulated remains elusive. Here we identify a new circular RNA (circRNA)
circKcnt2
that is induced in ILC3s during intestinal inflammation. Deletion of
circKcnt2
causes gut ILC3 activation and severe colitis in mice. Mechanistically,
circKcnt2
, as a nuclear circRNA, recruits the nucleosome remodeling deacetylase (NuRD) complex onto
Batf
promoter to inhibit Batf expression; this in turn suppresses
Il17
expression and thereby ILC3 inactivation to promote innate colitis resolution. Furthermore,
Mbd3
−/−
Rag1
−/−
and
circKcnt2
−/−
Rag1
−/−
mice develop severe innate colitis following dextran sodium sulfate (DSS) treatments, while simultaneous deletion of
Batf
promotes colitis resolution. In summary, our data support a function of the circRNA
circKcnt2
in regulating ILC3 inactivation and resolution of innate colitis.
Type 3 innate lymphoid cells (ILC3) are involved in maintaining gut immune homeostasis. Here the authors identify a circular RNA,
circKcnt2
, to be induced in ILC3s from inflamed gut, yet
circKcnt2
deletion aggravates mouse experimental colitis, thereby implicating
circKcnt2
as a potential feedback regulator of ILC3 activation and gut immunity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/s41467-020-17944-5 |